| 25/06/21 | NattoPharma ASA : - Delisting | AQ |
| 15/06/21 | NattoPharma : Received application for delisting | AQ |
| 14/06/21 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/06/21 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/06/21 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 08/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 09/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 04/11/2004 |
| Director/Board Member | 52 | 01/02/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| +1.89% | +3.20% | +59.70% | +165.18% | 1,062B | |
| -0.24% | +0.45% | +50.64% | +52.02% | 619B | |
| -0.95% | -5.26% | +24.23% | +65.08% | 431B | |
| +2.34% | +5.68% | +50.02% | +41.10% | 358B | |
| +1.27% | +0.19% | +36.31% | +41.17% | 293B | |
| +1.37% | -4.94% | +9.66% | +10.31% | 247B | |
| -0.73% | +4.44% | +42.22% | +66.41% | 219B | |
| +4.18% | -0.11% | -0.87% | -43.90% | 200B | |
| -0.68% | -0.32% | +18.66% | +66.32% | 162B | |
| Average | +1.18% | -1.90% | +32.29% | +51.52% | 399.14B | |
| Weighted average by Cap. | +0.77% | -0.83% | +41.27% | +78.39% |
Employees
18
Sector
Pharmaceuticals
